Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder

Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

Article Information

vol. 350 no. 3 543-551
DOI 
https://doi.org/10.1124/jpet.114.214031
PubMed 
24928951
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 16, 2014
  • Accepted June 12, 2014
  • Published online July 22, 2014.

Article Versions

Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Morihiro Fujimura,
  2. Naoki Izumimoto,
  3. Shinobu Momen,
  4. Satoru Yoshikawa,
  5. Ryosuke Kobayashi,
  6. Sayoko Kanie,
  7. Mikito Hirakata,
  8. Toshikazu Komagata,
  9. Satoshi Okanishi,
  10. Tadatoshi Hashimoto,
  11. Naoki Yoshimura, and
  12. Koji Kawai
  1. Pharmaceutical Research Laboratories, Toray Industries, Inc., Kanagawa, Japan (M.F., N.I., S.M., S.Y., R.K., S.K., M.H., T.K., K.K.); Pharmaceutical Research Division, Takeda Pharmaceutical Co. Ltd., Kanagawa, Japan (S.O., T.H.); and Departments of Urology and Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (N.Y.)
  1. Address correspondence to:
    Dr. Morihiro Fujimura, Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555 Japan. E-mail: Morihiro_Fujimura{at}nts.toray.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2014 to December 2024

AbstractFullPdf
Jun 20142070119
Jul 20143201048
Aug 20143201436
Sep 201488812
Oct 2014611425
Nov 20145559
Dec 201424108
Jan 201520613
Feb 20152498
Mar 20151064
Apr 20152246
May 20151468
Jun 2015887
Jul 20151638
Aug 201513810
Sep 2015171013
Oct 20151928
Nov 201513811
Dec 2015181110
Jan 201618910
Feb 201613917
Mar 20164727
Apr 201623621
May 201610412
Jun 201613512
Jul 201610414
Aug 201616512
Sep 20168714
Oct 201641512
Nov 20168177
Dec 201621212
Jan 201702110
Feb 20172219
Mar 20171236
Apr 20173144
May 20171136
Jun 2017170
Jul 20171714
Aug 201741314
Sep 20171125
Oct 2017163
Nov 2017185
Dec 20172145
Jan 20180155
Feb 201841714
Mar 20180149
Apr 201823318
May 201822012
Jun 20181129
Jul 20183109
Aug 20182118
Sep 20180134
Oct 2018226
Nov 20182136
Dec 201811219
Jan 20190714
Feb 20191710
Mar 201911413
Apr 20190810
May 20191612
Jun 201981117
Jul 2019101115
Aug 20192818
Sep 20191315
Oct 20191410
Nov 20192135
Dec 2019687
Jan 2020457
Feb 202061913
Mar 20200155
Apr 2020054
May 2020543
Jun 2020252
Jul 2020383
Aug 2020802
Sep 20201600
Oct 20201403
Nov 20202001
Dec 20201511
Jan 20211311
Feb 20211926
Mar 20211022
Apr 20212320
May 2021921
Jun 2021421
Jul 20212022
Aug 20212011
Sep 2021711
Oct 20211910
Nov 20212612
Dec 20213112
Jan 20221317
Feb 2022820
Mar 2022920
Apr 20221305
May 20221211
Jun 20221732
Jul 20221012
Aug 20221210
Sep 2022903
Oct 2022710
Nov 2022611
Dec 2022812
Jan 20231622
Feb 20231420
Mar 20231210
Apr 20231811
May 20231117
Jun 20231131
Jul 20231334
Aug 2023414
Sep 2023510
Oct 2023905
Nov 20231612
Dec 20232120
Jan 20241410
Feb 20242911
Mar 20243611
Apr 20244125
May 20242030
Jun 20242412
Jul 20242321
Aug 20243323
Sep 20241502
Oct 2024933
Nov 2024800
Dec 2024953

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

A New Drug Candidate for Overactive Bladder

Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement